Yenepoya group exemplary in providing healthcare education, services: Minister Shripad Naik
Mangaluru: Minister of State for Tourism and Ports, Shipping and Waterways of India Shripad Naik on Monday commended the work of Yenepoya organisation and Health Services by imparting quality health education and services. He said the Yenepoya group was exemplary in its efforts in providing quality healthcare services.
He was speaking at the inauguration of the newly constructed building of Yenepoya deemed University’s Pharmacy College and Research Centre. He also inaugurated the Yenepoya Ayurveda College’s hospital building at the Naringana Ayush Campus.
“Even though Goa is the place where I grew up, the Yenepoya group has started a program to provide healthcare services in the name of my wife. It is truly remarkable.” He said while thanking the Yenepoya group.
Deputy Leader of Opposition in Karnataka State Assembly, UT Khader who was present as the Chief Guest, said the Yenepoya Pharmacy College is another step towards providing facilities of both Allopathy and Ayurveda to the people and one from which patients can benefit.
Yenepoya Abdullah Kunhi, the Chancellor of Yenepoya deemed university, presided over the event and thanked all those who contributed to the growth of Yenepoya Medical Education Institutions. He said that he would also express his gratitude to the minister for allowing them to provide health services in memory of his late wife.
During the event, the Yenepoya group also announced that it would adopt the Kinya village under Arogya Gram Yojana. The 75th birthday of Yenepoya Abdullah Kunhi was also celebrated on the occasion.
Muhammad Kunhi, Chairman of Yenepoya Group of Companies, was the guest of honour. University’s registrar Dr. K. S. Gangadhar Somayaaji, Vice Chancellor Dr. M. Vijay Kumar, and Pro Vice-Chancellor Dr. B. H. Shri Pati Rao were present.
Kinya Gram Panchayath President Lakshmi, Naringana Gram Panchayat President Shailaja Shetty, Panchayat Development Officer were also present during the event.
Ayurveda College Principal Dr. Gururaj H. Welcomed the gathering while Yenepoya Pharmacy College Principal Dr. Muhammad Gulzar Ahmed presented vote of thanks.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Jamia prof receives Rs 94 lakh grant to formulate AI-driven drug to treat breast cancer
New Delhi (PTI): An associate professor at Jamia Millia Islamia has been awarded a research grant of approximately Rs 94 lakh by the prestigious ICMR to support research in leveraging Artificial Intelligence for treatment of breast cancer.
The Indian Council of Medical Research (ICMR) has granted funding to Raza to develop cutting-edge tools for AI-guided drug design, focusing on optimising drug compounds, identifying therapeutic targets, and formulating novel treatment strategies for breast cancer, a statement by the varsity said on Friday.
One such promising drug compound 'DdpMPyPEPhU' already patented by Raza will be further explored under this initiative, the statement said.
This research will address critical challenges in breast cancer treatment and is expected to yield transformative outcomes that could impact healthcare practices globally, it added.
The three-year funding will facilitate advanced experimentation, foster collaboration with leading experts, and accelerate the development of innovative solutions for breast cancer treatment.
Jamia Vice-Chancellor Mazhar Asif and Registrar Md. Mahtab Alam Rizvi congratulated Raza on this accomplishment.
Asif stated, “This is a moment of immense pride for JMI. Raza’s recognition by ICMR underscores the university’s commitment to fostering research excellence and innovation. His groundbreaking work showcases JMI’s vital contributions to integrating AI in healthcare research.”
Expressing gratitude for the recognition, Raza said, “I am deeply honoured to receive this grant from ICMR. It represents a tremendous opportunity to advance our research on AI- driven drug design and contribute to better health outcomes for millions. I am thankful to my research team, collaborators and ICMR for their unwavering support.”
Raza is known for his research in the application of AI in healthcare, focusing on designing and optimising drug compounds through AI-based multitarget docking, molecular simulations, and genomics-driven personalised medicine.
